Literature DB >> 7810813

Filariasis testing in a jird model: new drug leads from some old standbys.

K E Kinnamon1, D L Klayman, B T Poon, J W McCall, M T Dzimianski, S J Rowan.   

Abstract

A total of 65 compounds, most of which were from chemical classes having members known to be active against one or more parasitic organisms, were evaluated against Brugia pahangi and Acanthocheilonema viteae for macrofilaricidal activity in male Mongolian jirds (Meriones unguiculatus). Sixteen of the 65 compounds tested suppressed the number of parasites. Of these 16, three were suppressive for B. pahangi, 10 for A. viteae, and three for both parasites. The antibiotic nigericin and the antihistaminic isothipendyl were found to be most active.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7810813     DOI: 10.4269/ajtmh.1994.51.791

Source DB:  PubMed          Journal:  Am J Trop Med Hyg        ISSN: 0002-9637            Impact factor:   2.345


  3 in total

1.  A controlled trial to assess the effect of quinine, chloroquine, amodiaquine, and artesunate on Loa loa microfilaremia.

Authors:  Joseph Kamgno; Patrick Nguipdop Djomo; Sébastien D Pion; Björn Thylefors; Michel Boussinesq
Journal:  Am J Trop Med Hyg       Date:  2010-03       Impact factor: 2.345

2.  Bis[N,N-dimethyl-1-(10H-pyrido[3,2-b][1,4]benzothia-zin-10-yl)propan-2-aminium] tetrakis-(thio-cyanato-κN)cobaltate(II).

Authors:  H K Arunkashi; S Jeyaseelan; Suresh Babu Vepuri; H D Revanasiddappa; H C Devarajegowda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-06-16

3.  Macrofilaricidal Benzimidazole-Benzoxaborole Hybrids as an Approach to the Treatment of River Blindness: Part 1. Amide Linked Analogs.

Authors:  Tsutomu Akama; Yvonne R Freund; Pamela W Berry; David S Carter; Eric E Easom; Kurt Jarnagin; Christopher S Lunde; Jacob J Plattner; Fernando Rock; Rianna Stefanakis; Chelsea Fischer; Christina A Bulman; Kee Chong Lim; Brian M Suzuki; Nancy Tricoche; Abdelmoneim Mansour; Utami DiCosty; Scott McCall; Ben Carson; John W McCall; James McKerrow; Marc P Hübner; Sabine Specht; Achim Hoerauf; Sara Lustigman; Judy A Sakanari; Robert T Jacobs
Journal:  ACS Infect Dis       Date:  2020-01-14       Impact factor: 5.084

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.